Rapport Therapeutics, Inc. · NASDAQ:RAPP
Johnson & Johnson's stake in Rapport Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 22, 2025
Johnson & Johnson's stake in Rapport Therapeutics, Inc. fell to 4.90%, 1,784,517 shares, as a passive investor on Sep 30, 2025. Filed Oct 22, 2025 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 1,784,517
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JOHNSON & JOHNSON | 4.90% | 1,784,517 |
| Johnson & Johnson Innovation - JJDC, Inc. | 4.90% | 1,784,517 |